Taisho Pharmaceutical Holdings Co (TSE:4581) Construction In Progress : 円5,121 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Construction In Progress?

Taisho Pharmaceutical Holdings Co's quarterly construction in progress declined from Jun. 2023 (円25,103 Mil) to Sep. 2023 (円5,430 Mil) and declined from Sep. 2023 (円5,430 Mil) to Dec. 2023 (円5,121 Mil).

Taisho Pharmaceutical Holdings Co's annual construction in progress increased from Mar. 2021 (円6,577 Mil) to Mar. 2022 (円13,434 Mil) and increased from Mar. 2022 (円13,434 Mil) to Mar. 2023 (円21,911 Mil).

Taisho Pharmaceutical Holdings Co Construction In Progress Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Construction In Progress Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Construction In Progress

Get a 7-Day Free Trial

246.00

2,490.00

6,577.00

13,434.00

21,911.00

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Construction In Progress	Get a 7-Day Free Trial															23,524.00	21,911.00	25,103.00	5,430.00	5,121.00

Taisho Pharmaceutical Holdings Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines